Targeted therapies: Defining the best-in-class in NSCLC

Nat Rev Clin Oncol. 2017 Aug;14(8):457. doi: 10.1038/nrclinonc.2017.99. Epub 2017 Jun 27.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carbazoles
  • Carcinoma, Non-Small-Cell Lung*
  • Crizotinib
  • Humans
  • Lung Neoplasms*
  • Piperidines
  • Receptor Protein-Tyrosine Kinases

Substances

  • Carbazoles
  • Piperidines
  • Crizotinib
  • Receptor Protein-Tyrosine Kinases
  • alectinib